Back
NOVN.SW logo

NOVARTIS N (NOVN.SW)

default
NOVN.SW · EBS · CHF
New to investing? How to read this page →
Fr127.44
−0.38%
Watch Compare
Price · 1 year
Watch+ Add to portfolio
Loading live analysis…
Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS
CHF 5.82
ROE
30.8%
Gross margin
76.0%
Debt/Equity
0.76x
Revenue growth
2.2%

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen StocksLearn Intrinsic ValueTrading SignalsCompare Stocks

Explore more

More in default →More in Drug Manufacturers - General →Stocks in CH →Stocks on EBS →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

Vanguard High Dividend Yield ETVYMISHARES PLC ISHARES CORE FTSE10ISF.LGrayscale Bitcoin Mini Trust (BBTCVanguard S&P 500 ETFVOOSchwab US Dividend Equity ETFSCHDVANGUARD FUNDS PLC VANGUARD FTSVWRP.L

About NOVARTIS N

 

Weekly undervalued picks (like NOVN.SW)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.